Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Bezlotoxumab | CDB-1; MK-6072; MBL-CDB1; MDX-1388 | Approved | Merck Sharp & Dohme Corp | Zinplava | Japan | Clostridium Infections; Diarrhea | Merck Sharp & Dohme Corp | 2016-10-21 | Multiple Organ Failure; Inflammatory Bowel Diseases; Death; Clostridium Infections; Diarrhea | Details |
This web search service is supported by Google Inc.